These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 12846227)
21. Back to basics: diuretics as first-line agents in the treatment of hypertension. Mandal VJ J Am Geriatr Soc; 2004 Jul; 52(7):1210-1. PubMed ID: 15209664 [No Abstract] [Full Text] [Related]
22. Drugs for hypertension. Treat Guidel Med Lett; 2005 Jun; 3(34):39-48. PubMed ID: 15912125 [No Abstract] [Full Text] [Related]
23. Results of ALLHAT: is this the final answer regarding initial antihypertensive drug therapy? Moser M Arch Intern Med; 2003 Jun; 163(11):1269-73. PubMed ID: 12796062 [No Abstract] [Full Text] [Related]
24. [Management of hypertension in upheaval?]. Zidek W; Paul M Dtsch Med Wochenschr; 2005 Nov; 130(46):2627. PubMed ID: 16281156 [No Abstract] [Full Text] [Related]
26. Selecting antihypertensive medication in patients with essential hypertension in Malaysia. Ong HT; Rozina G Med J Malaysia; 2009 Mar; 64(1):3-11. PubMed ID: 19852313 [No Abstract] [Full Text] [Related]
27. [Current features of antihypertensive drug treatment]. Luño J; García de Vinuesa S Rev Clin Esp; 1999 Dec; 199(12):834-9. PubMed ID: 10687418 [No Abstract] [Full Text] [Related]
28. Hypertension arm of ADVANCE defines extent of renal protection using perindopril/indapamide in type 2 diabetics. Cardiovasc J Afr; 2008; 19(4):226. PubMed ID: 18776973 [No Abstract] [Full Text] [Related]
29. [Classification and risk stratification in hypertension Recommendations of the European Society for Hypertension (ESH)]. Zidek W MMW Fortschr Med; 2003 Nov; 145(45):41-2. PubMed ID: 14699807 [No Abstract] [Full Text] [Related]
30. Benefits and risks of combination therapy in hypertension. Node K Hypertens Res; 2009 Sep; 32(9):727-8. PubMed ID: 19609269 [No Abstract] [Full Text] [Related]
31. Benazepril plus amlodipine or hydrochlorothiazide for hypertension. Strauss MH; Weinstein J; Newton GE N Engl J Med; 2009 Mar; 360(11):1148; author reply 1149-50. PubMed ID: 19283888 [No Abstract] [Full Text] [Related]
32. ASCOT a four horse race. Sever P J Renin Angiotensin Aldosterone Syst; 2005 Sep; 6(2):51-4. PubMed ID: 16470483 [No Abstract] [Full Text] [Related]
35. Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. Kjeldsen SE; Julius S Am Heart J; 2004 Nov; 148(5):747-54. PubMed ID: 15523303 [TBL] [Abstract][Full Text] [Related]
36. Effects of treatment of hypertension on cardiovascular outcome in type 2 diabetes. Migdalis IN Res Commun Mol Pathol Pharmacol; 2006; 119(1-6):105-14. PubMed ID: 17974100 [No Abstract] [Full Text] [Related]
37. Hypertension strategies in the third millennium: conservatism, evidence and the folly of speculation. McIntyre HF Int J Clin Pract; 2009 Jan; 63(1):7-14. PubMed ID: 19125987 [No Abstract] [Full Text] [Related]
38. [Antihypertensive therapy in diabetic patients. What do the new data mean for the practice?]. Holzgreve H MMW Fortschr Med; 2007 Sep; 149(38):19. PubMed ID: 18018408 [No Abstract] [Full Text] [Related]
39. [Development of various forms of hypertension and a new assessment of antihypertensive medication]. Middeke M Dtsch Med Wochenschr; 2006 Jun; 131(25-26):1449-51. PubMed ID: 16794973 [No Abstract] [Full Text] [Related]
40. Combination therapy with amlodipine/benazapril (CCB/ACEI) superior to hydrochlorothiazide/benazapril in high-risk hypertensive patients. Cardiovasc J Afr; 2008; 19(3):163. PubMed ID: 18568181 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]